Pharma Giant Increases Already-Sizable Montco Presence, Inks Deal for 78,000 Square Feet in Lower Gwynedd

By

An aerial view of Spring House Innovation Park in Lower Gwynedd
Image via Spring House Innovation Park.
An aerial view of Spring House Innovation Park in Lower Gwynedd.

Merck, the pharmaceutical giant with sizable operations in West Point, is one of four life sciences companies that have signed a deal for space at Spring House Innovation Park in Lower Gwynedd, writes Natalie Kostelni for the Philadelphia Business Journal.

The four deals total 117,000 square feet and bring the 14-building, 600,000-square-foot complex to 60 percent occupancy.

The Merck deal is the biggest in the latest batch. The company has leased a full 78,000-square-foot lab building on the campus.

“Merck is committed to being the premier, research-intensive biopharmaceutical company, bringing creative minds together to transform world-class science into life-changing medicines and vaccines,” said the company. “After evaluating several options, the Spring House Innovation Park was considered the optimal choice to build upon our long-standing presence in Pennsylvania, as an active member of the SHIP campus community.”

The new lab space will support the company’s vaccine pipeline.

The remaining three deals include Seres Therapeutics, a microbiome therapeutics company with 7,000 square feet in Building 9, Tavotek Biotherapeutics, which expanded its existing space to 4,000 square feet, and FlowMetric, a contract research organization that took 26,000 square feet in Building 4.

Read more about the four deals in the Philadelphia Business Journal.

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Advertisement